ClinicalTrials.gov record
Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon
COMPLETED · NCT01280266
Trial record
NCT IDNCT01280266
Status
COMPLETED
Study type
INTERVENTIONAL
Phase
PHASE2, PHASE3
Enrollment
29
Conditions
Raynaud Phenomenon
Interventions
Udenafil or Amlodipine
Locations
Seoul National University Hospital, Seoul, South Korea
Indexed topics
Last update
2012-12-07